A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.
den Heijer JM, Kruithof AC, Moerland M, Walker M, Dudgeon L, Justman C, Solomini I, Splitalny L, Leymarie N, Khatri K, Cullen VC, Hilt DC, Groeneveld GJ, Lansbury P.
den Heijer JM, et al. Among authors: kruithof ac.
Mov Disord. 2023 Jul;38(7):1197-1208. doi: 10.1002/mds.29346. Epub 2023 May 17.
Mov Disord. 2023.
PMID: 37195859
Clinical Trial.